69639-103 : Aloxi .05 mg/ml Intravenous Injection


NDC: 69639-103
Labeler: Helsinn Therapeutics (U.s.), Inc.
Product Type: Human Prescription Drug
Drug Name:  Aloxi
Dosage Form: Intravenous Injection
Application #: NDA021372
Rev. Date: 


NDC Package Codes:

  • 69639-103-01: 1 VIAL IN 1 CARTON (69639‑103‑01) > 5 ML IN 1 VIAL
  • 69639-103-05: 1 VIAL IN 1 CARTON (69639‑103‑05) > 1.5 ML IN 1 VIAL

Active Ingredients:

  • Palonosetron Hydrochloride

Dosage Strength:

  • .05 mg/mL

Pharmaceutical Classes:

  • Serotonin 3 Receptor Antagonists [MoA]
  • Serotonin-3 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 69639-104 Aloxi .5 mg/.5mg Oral Capsule by Helsinn Therapeutics (U.s.), Inc.
  • 62856-797 Aloxi .25 mg/5ml Intravenous Injection by Eisai, Inc
  • 62856-798 Aloxi .075 mg/1.5ml Intravenous Injection by Eisai, Inc
  • 62856-799 Aloxi 0.5 mg (Palonosetron Hydrochloride 0.056 mg) Oral Capsule by Eisai

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69639-103 QR Code

< Prev: 69639-102Next: 69639-104 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.